Table 2.
Overview of mouse models for SCA 1.
B05 transgenic mice (B05) | Sca1 154Q/2Q mice (154Q/2Q) | |
---|---|---|
Phenotype | Motor incoordination, ataxia (12 weeks), no cognitive impairment | motor incoordination, muscle wasting, cognitive impairment, memory deficits |
Physical Onset | 5 weeks | 7–8 weeks |
Course of the disease | Normal life span | Premature, 35–45 weeks |
Neuropathology | PC loss, Bergmann glial proliferation, shrinkage and gliosis of molecular layer | Reduced dendritic arborization of PCs (early stage) |
Neuronal intranuclear inclusions and PC loss (advanced disease) | ||
Purkinje neuron dendritic and somatic atrophy | Hypocampal synaptic dysfunction but no significant loss | |
Mechanism | Overexpression of polyQ-ATXN1 (82 CAG repeats) under the control of Purkinje Cell pcp2 promoter | Expanded repeat of 154 CAGs was inserted into the mouse Sca 1 locus (knock-in) |
References | Burright et al., 1995; Clark et al., 1997 | Watase et al., 2002 |